Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase

被引:142
作者
Oscarson, M
Gullstén, H
Rautio, A
Bernal, ML
Sinues, B
Dahl, ML
Stengård, JH
Pelkonen, O
Raunio, H
Ingelman-Sundberg, M
机构
[1] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-17177 Stockholm, Sweden
[2] Oulu Univ, Dept Pharmacol & Toxicol, FIN-90220 Oulu, Finland
[3] Univ Zaragoza, Dept Pharmacol & Physiol, ES-5009 Zaragoza, Spain
[4] Huddinge Univ Hosp, Karolinska Inst, Dept Med Lab Sci & Technol, Div Clin Pharmacol, S-14186 Huddinge, Sweden
[5] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland
关键词
cytochrome P450; coumarin; allele; genotype; phenotype; methoxyflurane;
D O I
10.1016/S0014-5793(98)01297-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 2A6 (CYP2A6) is a polymorphic enzyme responsible for the oxidation of certain precarcinogens and drugs and is the major nicotine C-oxidase, The role of CYP2A6 for nicotine elimination was emphasised recently by the finding that smokers carrying defective CYP2A6 alleles consumed fewer cigarettes [Pianezza et al, (1998) Nature 393, 750]. The method used for CYP2A6 genotyping has, however, been found to give erroneous results with respect to the coumarin hydroxylase phenotype, a probe reaction for the CYP2A6 enzyme. The present study describes an allele-specific PCR genotyping method that identifies the major defective CYP2A6 allele and accurately predicts the phenotype, An allele frequency of 1-3% was observed in Finnish, Spanish, and Swedish populations, much lower than described previously. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 40 条
  • [1] METHODS AND REAGENTS - TIPS AND TRICKS FOR LONG AND ACCURATE PCR - REPLY
    BARNES, WM
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (08) : 342 - 342
  • [2] Benowitz N L, 1997, NIDA Res Monogr, V173, P48
  • [3] BERNAL ML, 1998, UNPUB
  • [4] HIGH VARIABILITY OF NITROSAMINE METABOLISM AMONG INDIVIDUALS - ROLE OF CYTOCHROMES P450 2A6 AND 2E1 IN THE DEALKYLATION OF N-NITROSODIMETHYLAMINE AND N-NITROSODIETHYLAMINE IN MICE AND HUMANS
    CAMUS, AM
    GENESTE, O
    HONKAKOSKI, P
    BEREZIAT, JC
    HENDERSON, CJ
    WOLF, CR
    BARTSCH, H
    LANG, MA
    [J]. MOLECULAR CARCINOGENESIS, 1993, 7 (04) : 268 - 275
  • [5] METABOLISM OF NICOTINE BY HUMAN LIVER-MICROSOMES - STEREOSELECTIVE FORMATION OF TRANS-NICOTINE N'-OXIDE
    CASHMAN, JR
    PARK, SB
    YANG, ZC
    WRIGHTON, SA
    JACOB, P
    BENOWITZ, NL
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (05) : 639 - 646
  • [6] EFFECTIVE AMPLIFICATION OF LONG TARGETS FROM CLONED INSERTS AND HUMAN GENOMIC DNA
    CHENG, S
    FOCKLER, C
    BARNES, WM
    HIGUCHI, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5695 - 5699
  • [7] COMPARISON OF A NOVEL THIN-LAYER CHROMATOGRAPHIC-FLUORESCENCE DETECTION METHOD WITH A SPECTROFLUOROMETRIC METHOD FOR THE DETERMINATION OF 7-HYDROXYCOUMARIN IN HUMAN URINE
    CHOLERTON, S
    IDLE, ME
    VAS, A
    GONZALEZ, FJ
    IDLE, JR
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (02): : 325 - 330
  • [8] HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1
    CRESPI, CL
    PENMAN, BW
    LEAKEY, JAE
    ARLOTTO, MP
    STARK, A
    PARKINSON, A
    TURNER, T
    STEIMEL, DT
    RUDO, K
    DAVIES, RL
    LANGENBACH, R
    [J]. CARCINOGENESIS, 1990, 11 (08) : 1293 - 1300
  • [9] GENETICALLY VARIABLE METABOLISM OF ANTIDEPRESSANTS AND NEUROLEPTIC DRUGS IN MAN
    DAHL, ML
    BERTILSSON, L
    [J]. PHARMACOGENETICS, 1993, 3 (02): : 61 - 70
  • [10] ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION
    DAHL, ML
    JOHANSSON, I
    PALMERTZ, MP
    INGELMANSUNDBERG, M
    SJOQVIST, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) : 12 - 17